Phase 3 AKI Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
Acute Kidney Injury (AKI)Regional Citrate Anticoagulation (RCA)Continuous Renal Replacement Therapy (CRRT)
Vantive Health LLC40 enrolled14 locationsNCT05399537
Recruiting
Phase 3
AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Corneal EdemaCorneal Endothelial DysfunctionFuchs Endothelial Corneal Dysfunction+1 more
Aurion Biotech120 enrolled12 locationsNCT07368959
Recruiting
Phase 3
NO During CPB in Neonates to Reduce Risk of AKI
SurgeryAKICHD - Congenital Heart Disease
Children's Hospital Medical Center, Cincinnati40 enrolled1 locationNCT04216927
Recruiting
Phase 2Phase 3
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
BiomarkersAKI - Acute Kidney InjuryCKD+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran100 enrolled1 locationNCT05713851
Recruiting
Phase 3
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Kawasaki Disease
Assistance Publique - Hôpitaux de Paris84 enrolled1 locationNCT04656184
Completed
Phase 2Phase 3
Clinical trial of a Chinese herbal medicine for the treatment of prediabetes and mild diabetes
Mild diabetes defined as those with diabetes diagnosed within 5 yrs of enrolment in the clinical trial, diet and exercise controlled and not taking any medications.Impaired glucose tolerance defined as having a fasting blood glucose <7.8 mmol and a 2 hour post prandial blood glucose >7.8 but <11.00
Xiyuan Hospital100 enrolled1 locationACTRN12612000128897
Recruiting
Phase 3
Evaluating the Utility of a Patient Decision Aid for Prospective Participants in the Trans-Tasman Radiation Oncology Group Radiotherapy - Adjuvant Versus Early Salvage Prostate Cancer Trial
Decision-making for clinical trial participation in men with prostate cancer who have positive margins and/or pathologic stage T3 (pT3; cancer extending beyond the capsule of the prostate gland) disease following radical prostatectomy, aged over 18 years.
Psycho-Oncology Cooperative Research Group (PoCoG)150 enrolled2 locationsACTRN12611001024932